Federated Hermes, Inc. Acrivon Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

  • $52.5 Billion
  • Q3 2025

A detailed history of Federated Hermes, Inc. transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,426 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,426
Previous 2,318 4.66%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
BUY
N/A
108 Added 4.66%
2,426 $0
Q2 2025

Aug 13, 2025
BUY
N/A
2,318 New
2,318 $0
Q3 2023

Nov 13, 2023
SELL
N/A
-78,036 Reduced 25.64%
226,375 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-309,214 Reduced 50.39%
304,411 $0
Q1 2023

May 08, 2023
SELL
N/A
-209,675 Reduced 25.47%
613,625 $0
Q4 2022

Feb 13, 2023
BUY
N/A
823,300 New
823,300 $0

Others Institutions Holding ACRV

# of Institutions
52
Shares Held
18.4M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email